Stanley-Laman Group’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,114
Closed -$252K 254
2022
Q4
$252K Buy
+11,114
New +$252K 0.05% 189